165 related articles for article (PubMed ID: 31183205)
1. Interleukin-6 as a biomarker in patients with hepatobiliary cancers.
Gosain R; Anwar S; Miller A; Iyer R; Mukherjee S
J Gastrointest Oncol; 2019 Jun; 10(3):537-545. PubMed ID: 31183205
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
Chiorean EG; Ramasubbaiah R; Yu M; Picus J; Bufill JA; Tong Y; Coleman N; Johnston EL; Currie C; Loehrer PJ
Oncologist; 2012; 17(1):13. PubMed ID: 22210086
[TBL] [Abstract][Full Text] [Related]
3. Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis.
Kokabi N; Camacho JC; Xing M; El-Rayes BF; Spivey JR; Knechtle SJ; Kim HS
Cancer; 2015 Jul; 121(13):2164-74. PubMed ID: 25847227
[TBL] [Abstract][Full Text] [Related]
4. High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma.
Bergis D; Kassis V; Ranglack A; Koeberle V; Piiper A; Kronenberger B; Zeuzem S; Waidmann O; Radeke HH
Transl Oncol; 2013 Jun; 6(3):311-8. PubMed ID: 23730411
[TBL] [Abstract][Full Text] [Related]
5. Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged.
Alabraba E; Joshi H; Bird N; Griffin R; Sturgess R; Stern N; Sieberhagen C; Cross T; Camenzuli A; Davis R; Evans J; O'Grady E; Palmer D; Diaz-Nieto R; Fenwick S; Poston G; Malik H
Eur J Surg Oncol; 2019 Sep; 45(9):1660-1667. PubMed ID: 31014988
[TBL] [Abstract][Full Text] [Related]
6. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
[TBL] [Abstract][Full Text] [Related]
7. Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma.
Kim MJ; Jang JW; Oh BS; Kwon JH; Chung KW; Jung HS; Jekarl DW; Lee S
Cytokine; 2013 Nov; 64(2):516-22. PubMed ID: 24035756
[TBL] [Abstract][Full Text] [Related]
8. D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis.
Malaguarnera M; Latteri S; Bertino G; Madeddu R; Catania VE; Currò G; Borzì AM; Drago F; Malaguarnera G
Clin Exp Gastroenterol; 2018; 11():373-380. PubMed ID: 30323642
[TBL] [Abstract][Full Text] [Related]
9. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
[TBL] [Abstract][Full Text] [Related]
10. Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma.
Jang JW; Oh BS; Kwon JH; You CR; Chung KW; Kay CS; Jung HS
Cytokine; 2012 Dec; 60(3):686-93. PubMed ID: 22906998
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study.
Dutta D; Tatineni T; Yarlagadda S; Gupte A; Reddy SK; Madhavan R; Nair H; Sasidharan A; Kannan R; Pottayil SG; Holla R; Sudhindran S
Indian J Gastroenterol; 2021 Aug; 40(4):389-401. PubMed ID: 34694581
[TBL] [Abstract][Full Text] [Related]
12. The Presence of Portal Vein Thrombosis Alters the Classic Enhancement Associated with Diagnosis of Hepatocellular Carcinoma.
Umar NK; Badshah MB; Sandrasegaran K; Ghabril M; Agarwal S; Tann M; Lacerda M; Kwo PY
Dig Dis Sci; 2015 Jul; 60(7):2196-200. PubMed ID: 25777258
[TBL] [Abstract][Full Text] [Related]
13. IL-37b suppresses epithelial mesenchymal transition in hepatocellular carcinoma by inhibiting IL-6/STAT3 signaling.
Pu XY; Zheng DF; Shen A; Gu HT; Wei XF; Mou T; Zhang JB; Liu R
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):408-415. PubMed ID: 30201411
[TBL] [Abstract][Full Text] [Related]
14. Significance of serum ferritin as a prognostic factor in advanced hepatobiliary cancer patients treated with Korean medicine: a retrospective cohort study.
Song A; Eo W; Kim S; Shim B; Lee S
BMC Complement Altern Med; 2018 Jun; 18(1):176. PubMed ID: 29879960
[TBL] [Abstract][Full Text] [Related]
15. Portal Vein Thrombosis in Unresectable Hcc Cases: a Single Center Study of Prognostic Factors and Management in 140 Patients.
Abdelmaksoud AH; Mandooh S; Nabeel MM; Elbaz TM; Shousha HI; Monier A; Elattar IA; Abdelaziz AO
Asian Pac J Cancer Prev; 2017 Jan; 18(1):183-188. PubMed ID: 28240515
[TBL] [Abstract][Full Text] [Related]
16. A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma.
Chan SL; Mo FK; Wong CS; Chan CM; Leung LK; Hui EP; Ma BB; Chan AT; Mok TS; Yeo W
Cancer; 2012 Aug; 118(16):3984-92. PubMed ID: 22180222
[TBL] [Abstract][Full Text] [Related]
17. An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus: A Multicenter Study.
Zhang XP; Gao YZ; Chen ZH; Chen MS; Li LQ; Wen TF; Xu L; Wang K; Chai ZT; Guo WX; Shi J; Xie D; Wu MC; Yee Lau W; Cheng SQ
Hepatology; 2019 May; 69(5):2076-2090. PubMed ID: 30586158
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis.
Ventura P; Venturelli G; Marcacci M; Fiorini M; Marchini S; Cuoghi C; Pietrangelo A
Thromb Res; 2016 May; 141():189-95. PubMed ID: 27065203
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine Serum Levels as Prognostic Marker of Hepatocellular Carcinoma with Portal Vein Thrombosis.
Latteri S; Malaguarnera G; Catania VE; La Greca G; Bertino G; Borzì AM; Drago F; Malaguarnera M
Curr Mol Med; 2019; 19(7):532-538. PubMed ID: 31187711
[TBL] [Abstract][Full Text] [Related]
20. Acute Portal Vein Thrombosis Predicts Concomitant Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients.
Khoury T; Massarwa M; Hazou W; Daher S; Hakimian D; Benson AA; Ashqar T; Mahamid M; Yaari S
J Gastrointest Cancer; 2019 Dec; 50(4):759-762. PubMed ID: 30043228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
